Amanote Research
Register
Sign In
The Safety of Influenza Vaccine in Clinically Cured Leprosy Patients in China
Human Vaccines and Immunotherapeutics
- United States
doi 10.1080/21645515.2017.1390638
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Allergy
Immunology
Pharmacology
Date
December 14, 2017
Authors
Yi Zheng
Li Chen
Jie Zou
Zheng-Gang Zhu
Li Zhu
Jing Wan
Quan Hu
Publisher
Informa UK Limited
Related search
The Rate of Relapses in Patients Clinically Cured From Pulmonary Sarcoidosis
Ukrainian Pulmonology Journal
Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink
Archives of Pediatrics & Adolescent Medicine
Vaccine Safety and Social Media in China
American Journal of Infection Control
Epidemiology
Public Health
Health Policy
Infectious Diseases
Environmental
Occupational Health
Comparison of Immunogenicity and Safety of a Virosome Influenza Vaccine With Those of a Subunit Influenza Vaccine in Pediatric Patients With Cystic Fibrosis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Opportunities to Diagnose Active Tuberculosis in the Patients With Clinically Cured Respiratory Tuberculosis
Tuberkulëz i bolezni lëgkikh
Pulmonary
Infectious Diseases
Respiratory Medicine
Leprosy in China
Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine
JAMA - Journal of the American Medical Association
Medicine
Use of Influenza Vaccine in the Netherlands.
BMJ
